CVS Health Stock News

In the most recent trading session, CVS Health (CVS) closed at $69.75, indicating a +0.52% shift from the previous trading day.

CVS Health (CVS) closed at $69.39 in the latest trading session, marking a +1.15% move from the prior day.

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

As the earnings season gets underway on Wall Street, the euphoria of rapid gains is starting to wane. Economic uncertainties, geopolitical tensions and the ever-present threat of inflation have left i

The Investment Committee give you their top stocks to watch for the second half.

In the closing of the recent trading day, CVS Health (CVS) stood at $68.64, denoting a -1.58% change from the preceding trading day.

In a setting historically dominated by male leadership, women at the helm of major corporations is still considered something of a novelty. You don't see many articles about a company's first male CEO

With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access to health-related products and se

CVS Health (CVS) closed at $73.36 in the latest trading session, marking a -1.45% move from the prior day.

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

CVS Group's (AIM:CVSG) IT systems have been hit by a cyber attack, which is still affecting some operations at its veterinary practices.  The company said it has informed the Information Commissio

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy

CVS Caremark, the pharmacy benefit management subsidiary of CVS Health Corp , will add Perrigo's birth control pill to its preventive services oral contraceptives list and make it available at no cost

The decision by CVS could open the door for more people to prevent unintended pregnancies without a prescription.

A competition probe into Britain's veterinary market is unlikely to hit CVS Group (AIM:CVSG) PLC and Pets at Home Group PLC (LSE:PETS) as hard as feared, analysts have reassured. The Competition and M